Agios Pharmaceuticals Corporation

Agios Pharmaceuticals is a biopharmaceutical company discovers and develops therapeutics in the field of cancer metabolism.
The intellectual property of Agios Pharmaceuticals includes 170 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Agios Pharmaceuticals has registered 28 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Technology: Drug Discovery
Industry: Pharma
Headquarters: The United States
Founded Date: 1/1/2008
Employees Number: 101-250
Funding Status: IPO
Total Funding: 119823937
Last Funding Type: Series C

Visit Website
Register and Claim Ownership